Form 4: Bausch Health Director John Paulson Acquires Shares in Lieu of Cash Compensation

Director John Paulson acquired 9,659 common shares of Bausch Health Companies Inc. on March 31, 2025, in lieu of cash compensation for board service.

Summary

• On March 31, 2025, John Paulson, a director of Bausch Health Companies Inc., acquired 9,659 common shares.
• The shares were received as restricted share units (RSUs) in lieu of cash compensation for Paulson's service on the Issuer's Board of Directors for the quarter ending March 31, 2025.
• The price of the shares was $6.47.
• Following the transaction, Paulson directly owns 277,708 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The acquisition of shares by a director is generally viewed positively, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Directors often receive equity compensation as part of their overall remuneration package, aligning their interests with those of shareholders. This is a common practice in publicly traded companies.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across various industries.
• The amount and type of equity compensation can vary significantly based on company size, performance, and industry benchmarks.
• Comparing Bausch Health's director compensation structure with peers like Teva Pharmaceuticals or Mylan (now Viatris) would provide a better understanding of its relative competitiveness.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Bausch Health, John Paulson, Director, Share Acquisition, Restricted Share Units, Compensation, Form 4